Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
365 GBX | 0.00% | +6.26% | +4.14% |
Mar. 25 | Chemring Director Ord sells GBP500,000 in shares | AN |
Mar. 18 | Stocks downbeat before central bank rate storm | AN |
Sales 2024 * | 508M 634M | Sales 2025 * | 548M 684M | Capitalization | 994M 1.24B |
---|---|---|---|---|---|
Net income 2024 * | 54M 67.46M | Net income 2025 * | 59M 73.71M | EV / Sales 2024 * | 2.09 x |
Net Debt 2024 * | 67.1M 83.83M | Net Debt 2025 * | 72.82M 90.97M | EV / Sales 2025 * | 1.95 x |
P/E ratio 2024 * |
19.2
x | P/E ratio 2025 * |
17.5
x | Employees | 2,600 |
Yield 2024 * |
2.15% | Yield 2025 * |
2.37% | Free-Float | 98.24% |
Latest transcript on Chemring Group PLC
1 day | -0.34% | ||
1 week | +5.87% | ||
Current month | +0.18% | ||
1 month | +2.15% | ||
3 months | +3.75% | ||
6 months | +31.05% | ||
Current year | +3.75% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Ord
CEO | Chief Executive Officer | 57 | 18-05-31 |
Director of Finance/CFO | 45 | Oct. 31 | |
Andrew Davies
BRD | Director/Board Member | 57 | 16-05-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sarah Ellard
BRD | Director/Board Member | 54 | 93-12-31 |
Laurie Bowen
BRD | Director/Board Member | 62 | 19-07-31 |
Chairman | 70 | 16-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 365 | 0.00% | 380 201 |
24-04-24 | 365 | +0.14% | 702,238 |
24-04-23 | 364.5 | +0.55% | 946,012 |
24-04-22 | 362.5 | +5.38% | 797,343 |
24-04-19 | 344 | +0.15% | 376,834 |
Delayed Quote London S.E., April 25, 2024 at 10:38 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.75% | 1.24B | |
+20.41% | 134B | |
+8.90% | 77B | |
+2.50% | 70.3B | |
+18.01% | 51.07B | |
-2.17% | 39.48B | |
+42.68% | 31.68B | |
+78.26% | 24.15B | |
+16.40% | 22.82B | |
+29.11% | 20.73B |
- Stock Market
- Equities
- CHG Stock